Phase I Trial of Taxol as a Radiation Sensitizer with Cisplatin in Advanced Cervical Cancer

By Chen M.D.   Paley P.J.   Potish R.A.   Twiggs L.B.  

Gynecologic Oncology, Vol. 67, Iss. 2, 1997-11 ,pp. : 131-136

Elsevier

Access to resources Recommend Favorite

Hyperfractionated Radiation Therapy plus Chemotherapy in Locally Advanced Cervical Cancer: Results of Two Phase I Dose- Escalation Gynecologic Oncology Group Trials

By Calkins A.R.   Harrison C.R.   Fowler W.C.   Gallion H.   Mangan C.E.   Husseinzadeh N.   Alvarez R.D.   Mychalczak B.   Podczaski E.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 349-355

Elsevier

Access to resources Recommend Favorite

Topotecan preceded by oxaliplatin using a 3 week schedule - a phase I study in advanced cancer patients

By Gross-Goupil M.   Lokiec F.   Lopez G.   Tigaud J.-M.   Hasbini A.   Romain D.   Misset J.-L.   Goldwasser F.  

European Journal of Cancer, Vol. 38, Iss. 14, 2002-09 ,pp. : 1888-1898

Elsevier

Access to resources Recommend Favorite

Phase I Study of Alternating Doublets of Topotecan/Carboplatin and Paclitaxel/Carboplatin in Patients with Newly Diagnosed, Advanced Ovarian Cancer

By Gordon A.N.   Hancock K.C.   Matthews C.M.   Messing M.   Stringer C.A.   Doherty M.G.   Teneriello M.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 129-135

Elsevier

Access to resources Recommend Favorite

Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study

By Stathopoulos George   Rigatos Sotiris   Christodoulou Christos   Malamos Nikos   Deliyiannis Filippos   Stathopoulos John   Skarlos Dimosthenis  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 3, 2004-09 ,pp. : 259-264

Springer Publishing Company

Access to resources Recommend Favorite